The 9^th GSCN Conference 2021 will take place from 6 - 8 October 2021 in Ulm in Southern Germany. Registration is open now - please register and submit an abstract for oral presentation and/or poster presentation. You find all necessary information here.

GSCN Annual Magazine 2020/21:
Stem Cell Research and Diseases II

Starting in 2021, the German Stem Cell Network (GSCN) and the Berlin Institute of Health (BIH) have entered into a close cooperation with the foundation of the "Dialog Platform Stem Cell Research".
Find the press release with more information here.

Through this White Paper, the GSCN and the Interdisciplinary  Research Group (IAG) Gene Technology Report of the Berlin-Brandenburg Academy of Sciences and Humanities (BBAW) hope to raise public awareness of this research field and stimulate an interdisciplinary public debate on organoids.
Read more

The GSCN has developed an exhibition for institutes, universities and teachers - 10 posters on topics of current stem cell research like diabetes, organoids, skin, ethics and many more. Each poster is accompanied by a website with videos, factsheets and an interactive quiz to deepen the information.
Link to the website in German: Stammzellen - Zellen fürs Leben
Link to the website in English: Stem Cells for Life
Link to the English posters coming soon.
Contact: gscn.office@mdc-berlin.de

Excellent research: GSCN Award Winners 2020 

The „GSCN 2020 Young Investigator Award“ goes to Prof. Dr. Barbara Treutlein of the Max Planck Institute of Evolutionary Anthropolgy, Leipzig, and the Department of Biosystems Science and Engineering at the ETH Zurich, Switzerland.
The „GSCN 2020 Female Scientist Award“ goes to Prof. Dr. Edith Heard, Director General of the European Molecular Biology Laboratory (EMBL) in Heidelberg.
The „GSCN 2020 Publication of the Year Award“ goes to Sergiy Velychko and Prof. Dr. Hans R. Schöler of the Max Planck Institute for Molecular Biomedicine in Munster.
Find the GSCN press release here:  Development of stem cells in the laboratory
Read more here.

Offers of unproven stem cell therapies for COVID-19 disease caused by the corona virus SARS-CoV-2

With the spreading COVID-19 pandemic, there is an urgent need for new treatments, especially for critically ill patients. Clinical trials, such as experiments with SARS-COV-2 vaccines, are in full swing. However, there is a significant increase in unproven and untested therapies worldwide, including unproven treatments based on "stem cells". The German Stem Cell Network (GSCN) as well as international scientific societies such as EuroStemCell (Statement), the International Society for Stem Cell Research (ISSCR Statement) and the International Society for Cell & Gene Therapy (ISCT Statement) strongly oppose the irresponsible offer of unproven cell-based treatments, especially in the context of such a severe pandemic. Affected individuals and families are urged to talk to healthcare professionals to obtain the best available information on COVID-19 disease and treatment options.